Investigation for Investors over Acquisition of Cepheid (NASDAQ:CPHD) Announced
The acquisition of Cepheid is under investigation over potential wrongdoing. The investigation was announced on behalf of investors, who currently hold NASDAQ:CPHD shares, concerning whether the takeover of Cepheid by Danaher Corporation for $53 per share is unfair to NASDAQ:CPHD stockholders.
View full press release